Point of care diagnostics market expected to reach $32.7 billion by 2022

Saturday, November 5, 2016

Pune: Global Point of Care Diagnostics Market is expected to grow at a CAGR (compound annual growth rate) of 9.7 percent to reach $32.7 billion by 2022, according to Wise Guy Reports.

The speed factor, particularly, is the utmost strength of POC diagnostics as quicker diagnosis facilitates sooner patient management. Increasing incidence of chronic disorders and contagious diseases, that need portable and quick diagnosis, is estimated to fuel the market growth.

Lack of co-ordination among healthcare centres, practitioners, and manufacturers is the major factor hindering the point of care diagnostics market.

Recently, the blood testing segment has been a major contributor to the market, strongly driven by portable glucose monitoring devices. Transmittable diseases, including HIV/AIDS, TB and hepatitis, will be a rising hub for POC moving ahead.

In 2015, North America commanded the POC diagnostics market accounting for more than 40% of the global revenue. Asia Pacific is projected to grow at a productive rate due to the presence of high unmet medical requirements, increase in disposable income and enhancement in healthcare infrastructure in emerging economies.

In future, countries such as Japan, China, India, Brazil and Mexico are projected to grow as hot spots for progress of POC technology, according to a statement.

The key players in global Point of Care Diagnostics market are Roche Diagnostics, Abbott Laboratories, Johnson & Johnson, BD (Becton, Dickinson), Siemens Healthcare, Bayer Healthcare, Nova Biomedical, Abaxis, Pharmatech, Nipro Diagnostics, Beckman Coulter, BioMerieux, Alere, Danaher and Spectral Diagnostics.

Categories: Diagnostics, NEWS

Tags: , ,

  More from Diagnostics

Next generation optical biometry devices market may grow to $450 million by 2028


Biosense Technologies raises $1 million in funding


Nuclear medicine can help avoid unnecessary angioplasty


Faulty gene identified as cause of obesity in world’s heaviest woman


Dr Lal PathLabs to open central labs in Kolkata, Lucknow


New blood test assists oncologists with tumour treatment optimization

Comments »

No comments yet.

Name (required)
E-mail (required - never shown publicly)
URI
Your Comment (smaller size | larger size)
You may use <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> in your comment.